Get the Stockscreener App
5.80
6.15%
-0.38
After Hours:
5.77
-0.03
-0.52%
Clene Inc stock is traded at $5.80, with a volume of 119.18K.
It is down -6.15% in the last 24 hours and up +56.76% over the past month.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
See More
Previous Close:
$6.18
Open:
$6.19
24h Volume:
119.18K
Relative Volume:
1.37
Market Cap:
$57.95M
Revenue:
$442.00K
Net Income/Loss:
$-30.46M
P/E Ratio:
-1.3004
EPS:
-4.46
Net Cash Flow:
$-27.47M
1W Performance:
-3.81%
1M Performance:
+56.76%
6M Performance:
+31.82%
1Y Performance:
-8.52%
1-Day Range:
$5.77
$6.4452
1-Week Range:
$5.77
$7.10
52-Week Range:
$2.2801
$7.10
Clene Inc Stock (CLNN) Company Profile
Name
Clene Inc
Sector
Industry
Phone
801-676-9695
Address
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Compare CLNN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
5.80 | 64.64M | 442.00K | -30.46M | -27.47M | -4.46 |
|
JBS
Jbs N V
|
15.78 | 34.85B | 60.44B | 2.01B | -373.53M | 1.5518 |
|
KHC
Kraft Heinz Co
|
26.13 | 31.54B | 25.31B | -5.27B | 3.49B | -4.49 |
|
K
Kellanova
|
79.43 | 27.48B | 12.64B | 1.35B | 650.00M | 3.81 |
|
GIS
General Mills Inc
|
49.92 | 26.74B | 19.64B | 2.56B | 2.48B | 4.55 |
|
MKC
Mccormick Co Inc
|
68.95 | 18.40B | 6.68B | 792.60M | 774.40M | 2.94 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-04-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-18-22 | Initiated | H.C. Wainwright | Buy |
| May-02-22 | Initiated | Canaccord Genuity | Buy |
| Sep-28-21 | Initiated | Oppenheimer | Outperform |
Clene Inc Stock (CLNN) Latest News
Benchmark Lowers Clene (NASDAQ:CLNN) Price Target to $31.00 - MarketBeat
Top 13 Nanotech Stocks to Watch Right Now! - timothysykes.com
Benchmark lowers Clene stock price target to $31 on funding concerns - Investing.com Nigeria
Clene Inc. Advances Toward NDA Submission for ALS Therapy CNM-Au8® - citybuzz -
What’s the profit margin of Clene Inc. Equity WarrantBond Market & Daily Entry Point Trade Alerts - Lancaster City Council
Is Clene Inc. Equity Warrant exposed to political risk2025 Winners & Losers & Low Risk High Reward Ideas - Lancaster City Council
| MarketBeat - MarketBeat
Price Clustering Detected in Clene Inc. Stock2025 Top Decliners & Stepwise Entry and Exit Trade Signals - beatles.ru
Will Clene Inc. benefit from AI trendsQuarterly Earnings Summary & Weekly Stock Breakout Alerts - beatles.ru
Clene presents preclinical data supporting CNM-Au8 for Parkinson’s disease - MSN
Clene Inc. Recovery Hinges on Volume Breakout2025 Price Action Summary & High Accuracy Trade Alerts - beatles.ru
Will Clene Inc. announce a stock splitOptions Play & Entry and Exit Point Strategies - beatles.ru
Is now the right time to enter Clene Inc. Equity WarrantEarnings Miss & Smart Investment Allocation Insights - 뉴스영
Short interest data insights for Clene Inc. Equity Warrant2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - Newser
Will Clene Inc. continue its uptrendRate Cut & Free Weekly Watchlist of Top Performers - Newser
What hedge funds are buying Clene Inc. Equity Warrant2025 Momentum Check & Fast Momentum Entry Tips - خودرو بانک
How to build a custom watchlist for Clene Inc. Equity WarrantBear Alert & Detailed Earnings Play Strategies - Newser
Is Clene Inc. a turnaround storyJuly 2025 Action & AI Optimized Trade Strategies - خودرو بانک
Signal strength of Clene Inc. stock in tech scanners2025 Support & Resistance & Safe Entry Zone Tips - Newser
Clene files prospectus supplement for $6.28 million stock offering - Investing.com
Clene Incfiles prospectus supplement for $6.28 million SharesSEC filing - MarketScreener
Clene files prospectus supplement for $6.28 million stock offering By Investing.com - Investing.com Canada
What’s the beta of Clene Inc. Equity Warrant stockEarnings Growth Summary & Real-Time Market Sentiment Alerts - خودرو بانک
Clene files to sell 491,496 shares of common stock by selling shareholders - MSN
Clene Expands Equity Distribution to Raise Capital - TipRanks
Clene's Share Sale by Selling Shareholders: What It Means for Investor Value and Market Sentiment - AInvest
Is Clene Inc. stock a buy or sellProduct Launch & Community Supported Trade Ideas - خودرو بانک
What data driven models say about Clene Inc.’s futureTrade Risk Assessment & Accurate Technical Buy Alerts - Newser
Clene stock maintains Buy rating at H.C. Wainwright on Parkinson’s data - Investing.com Nigeria
Using economic indicators to assess Clene Inc. potential2025 Short Interest & Verified Short-Term Trading Plans - Newser
Is Clene Inc. stock technically oversoldJuly 2025 Institutional & Reliable Price Breakout Alerts - خودرو بانک
Can a trend reversal in Clene Inc. Equity Warrant lead to recoveryPortfolio Risk Summary & Short-Term Swing Trade Alerts - Newser
What’s the MACD signal for Clene Inc. Equity WarrantQuarterly Market Summary & Verified Momentum Stock Watchlist - خودرو بانک
Clene Inc. Equity Warrant stock prediction for this weekTake Profit & Verified Momentum Stock Ideas - Newser
Custom strategy builders for tracking Clene Inc. Equity WarrantJuly 2025 Momentum & AI Powered Market Trend Analysis - Newser
What MACD and RSI say about Clene Inc.Trade Analysis Summary & Safe Capital Growth Trade Ideas - Newser
How to read the order book for Clene Inc.Weekly Trend Recap & Long-Term Safe Investment Plans - Newser
How moving averages guide Clene Inc. tradingOptions Play & Community Driven Trade Alerts - Newser
Should you hold or exit Clene Inc. nowWall Street Watch & Safe Swing Trade Setups - Newser
Clene's CNM-Au8 Shows Promise in Improving Cellular Health in Parkinson's Disease Model - citybuzz -
Historical volatility pattern of Clene Inc. visualizedTrade Risk Summary & Weekly High Return Stock Opportunities - Newser
Can Clene Inc. outperform in the next rallyQuarterly Earnings Summary & Consistent Income Trade Recommendations - خودرو بانک
Comparing Clene Inc. in custom built stock radarsQuarterly Trade Summary & Weekly Consistent Profit Watchlists - Newser
Clene Inc. Presents Promising Preclinical Data for CNM-Au8 in Parkinson’s Disease Model at H2 Therapeutics Stewardship Meeting - Quiver Quantitative
36% Metabolite Improvement: Clene's CNM-Au8 Drug Shows Breakthrough in Parkinson's Disease Treatment - Stock Titan
What’s Clene Inc. Equity Warrant’s historical returnMarket Sentiment Report & Daily Stock Trend Watchlist - خودرو بانک
Earnings visualization tools for Clene Inc. Equity WarrantJuly 2025 PreEarnings & Capital Efficient Trade Techniques - Newser
Will Clene Inc. benefit from macro trendsJuly 2025 Outlook & Weekly Return Optimization Alerts - Newser
Will Clene Inc. price bounce be sustainable2025 Technical Overview & Community Consensus Picks - Newser
Full technical analysis of Clene Inc. Equity Warrant stockJuly 2025 Pullbacks & Expert Verified Movement Alerts - Newser
What candlestick patterns are forming on Clene Inc. Equity WarrantTrade Ideas & Technical Pattern Based Signals - Newser
Clene Inc Stock (CLNN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):